Synthesis and antitumor activity of A-ring modified hexacyclic analogues of camptothecin.
- Author:
Di-zao LI
1
;
Cun-ying WANG
;
Xian-dao PAN
;
Hong-yan LIU
;
Zhao-di FU
;
Song WU
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Antineoplastic Agents; chemical synthesis; pharmacology; Camptothecin; analogs & derivatives; chemical synthesis; chemistry; pharmacology; Carcinoma, Hepatocellular; drug therapy; pathology; Cell Line, Tumor; drug effects; Female; Humans; Liver Neoplasms; drug therapy; pathology; Mice; Neoplasm Transplantation; Polycyclic Compounds; chemical synthesis; pharmacology
- From: Acta Pharmaceutica Sinica 2005;40(3):241-247
- CountryChina
- Language:English
-
Abstract:
AIMTo improve the biological activity of A-ring modified analogues of camptothecin.
METHODSA-ring modified camptothecins were synthesized from 10-hydroxycamptothecin or 7-ethyl-10-hydroxycamptothecin (SN-38) in three or four steps. Their cytotoxicity was evaluated using MTY assay, and their in vivo antitumnor activity against mouse liver cancer H22 was tested. Results Five hexacyclic camptothecins (6a, 6b, 6c, 7a and 7b) are target compounds, and ten camptothecin derivatives are new compounds.
CONCLUSIONThe modification of a 1,4-oxazine-2-one ring fused with positions 9 and 10 of A-ring will reduce the antitumor activity of camptothecins.
